arabic.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic).: "arise: a phase 3 randomized trial of erenumab for episodic migraine."..
.
yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital..
please keep our community civil. comments should remain on topic and be respectful..